✦ LIBER ✦

Pharmacogenetic determinants of variability in lipid-lowering response to pravastatin therapy

✍ Scribed by Hiroshi Takane; Masanori Miyata; Naoto Burioka; Chiaki Shigemasa; Eiji Shimizu; Kenji Otsubo; Ichiro Ieiri

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Determinants of the interindividual vari

✍ B. ROCCA; C. PATRONO 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 183 KB

Lipid Lowering Therapy with Fluvastatin

✍ A. Benesic; M. Zilly; F. Kluge; B. Weißbrich; R. Winzer; H. Klinker; P. Langmann 📂 Article 📅 2004 🏛 Springer-Verlag 🌐 English ⚖ 284 KB

Genetically determined apo B levels and

✍ A. ZAMBON; B. G. BROWN; J. E. HOKANSON; A. G. MOTULSKY; J. D. BRUNZELL 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 185 KB

Determinants of prognosis and response t

✍ Syma Iqbal; Heinz-Josef Lenz 📂 Article 📅 2001 🏛 Current Science Inc. 🌐 English ⚖ 323 KB

Apolipoprotein E genotype affects the re

✍ S. Tavintharan; S. C. Lim; Y. H. Chan; C. F. Sum 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 84 KB

Pharmacogenetics of CYP2C9 and interindi

✍ Takahashi, H; Echizen, H 📂 Article 📅 2003 🏛 Nature Publishing Group 🌐 English ⚖ 191 KB